Subscribe to RSS
DOI: 10.1055/s-2006-950332
The Synthesis of Cryptophycins
Publication History
Publication Date:
20 October 2006 (online)
Abstract
Nature provides a huge reservoir of highly diverse chemical compounds with interesting biological properties. Secondary metabolites continue to represent promising candidates for therapeutic applications and drugs are very often based on natural products. Frequently, the total synthesis of such compounds is a real challenge, and this also drives the development of new synthetic methodology.
This review article focuses on the biochemistry and chemistry of cryptophycins, a class of 16-membered macrocyclic depsipeptides. The first representative was isolated more than 15 years ago from cyanobacteria. With respect to structure, the class can be subdivided into two structural categories, containing either an epoxide or an alkene moiety. The bioactivity of cryptophycins is based on their ability to interact with tubulin. They display considerable tumour-selective cytotoxicity both against multidrug-resistant tumour cell lines and solid tumours implanted in mice. Consequently, cryptophycin derivatives are considered as potential antitumour drugs.
Despite the fact that the cryptophycins were discovered only recently, several different synthetic approaches have already been published. In addition to information on the synthesis of the subunits A-D, strategies for both their assembly and the macrocyclisation are compiled in this review.
-
1 Structural and Biological Features of Cryptophycins
-
1.1 The Cryptophycins: A Short History
-
1.2 Structural Features
-
1.3 Tubulin as a Drug Target
-
1.4 Biological Activity of Cryptophycins
-
1.5 Structure-Activity Relationship
-
2 Synthesis of the Building Blocks
-
2.1 Syntheses of Unit A with Two Stereogenic Centres
-
2.2 Syntheses of Unit A with Four Stereogenic Centres
-
2.3 Units B, C, and D
-
3 Coupling of Units and Cyclisation
-
3.1 Cyclisation between Units C and B
-
3.2 Cyclisation between Units A and B
-
3.3 Horner-Wadsworth-Emmons Reaction and Ring-Closing Metathesis
-
3.4 Other Cyclisation Methods
-
4 Epoxidation
-
4.1 m-Chloroperoxybenzoic Acid
-
4.2 Dimethyldioxirane
-
4.3 Diol-Epoxide Conversion
-
4.4 Halohydrins
-
5 Reactions of Cryptophycins
-
6 Conclusion and Outlook
Key words
drugs - medicinal chemistry - natural products - peptides - total synthesis
- 1
Schwartz RE.Hirsch CF.Sesin DF.Flor JE.Chartrain M.Fromtling RE.Harris GH.Salvatore MJ.Liesch JM.Yudin K. J. Ind. Microbiol. 1990, 5: 113 - 2
Golakoti T.Ohtani I.Patterson GML.Moore RE.Corbett TH.Valeriote FA.Demchik L. J. Am. Chem. Soc. 1994, 116: 4729 - 3
Golakoti T.Ogino J.Heltzel CE.Husebo TL.Jensen CM.Larsen LK.Patterson GML.Moore RE.Mooberry SL.Corbett TH.Valeriote FA. J. Am. Chem. Soc. 1995, 117: 12030 ; corrigendum in J. Am. Chem. Soc. 1996, 118, 3323 - 4 Symbiotic cyanobacteria as original source of arenastatin A have also been discussed:
Burja AM.Banaigs B.Abou-Mansour E.Burgess JG.Wright PC. Tetrahedron 2001, 57: 9347 ; and references cited therein - 5
Kobayashi M.Kurosu M.Ohyabu N.Wang W.Fujii S.Kitagawa I. Chem. Pharm. Bull. 1994, 42: 2196 - 6
Kobayashi M.Aoki S.Ohyabu N.Kurosu M.Wang W.Kitagawa I. Tetrahedron Lett. 1994, 35: 7969 - 7
Barrow RA.Hemscheidt T.Liang J.Paik S.Moore RE.Tius MA. J. Am. Chem. Soc. 1995, 117: 2479 - 8
Subbaraju GV.Golakoti T.Patterson GML.Moore RE. J. Nat. Prod. 1997, 60: 302 - 9
Chaganty S.Golakoti T.Heltzel C.Moore RE.Yoshida WY. J. Nat. Prod. 2004, 67: 1403 - 10
Eggen M.Georg GI. Med. Res. Rev. 2002, 22: 85 - 11
Hamel E.Covell DG. Curr. Med. Chem. 2002, 2: 19 - 12
Bai R.Schwartz RE.Kepler JA.Pettit GR.Hamel E. Cancer Res. 1996, 56: 4398 - 13
Stevenson JP.Sun W.Gallagher M.Johnson R.Vaughn D.Schuchter L.Algazy K.Hahn S.Enas N.Ellis D.Thornton D.O’Dwyer PJ. Clin. Cancer Res. 2002, 8: 2524 - 14
Nogales E.Wang H.-W.Niederstrasser H. Curr. Opin. Struct. Biol. 2003, 13: 256 ; and references cited therein - 15
Jordan MA.Wilson L. Nat. Rev. Cancer 2004, 4: 253 - 16
Hamel E. Peptide Sci. 2002, 66: 142 - 17
Jordan A.Hadfield JA.Lawrence NJ.McGown AT. Med. Res. Rev. 1998, 18: 259 - 18
Giannakakou P.Sacket D.Fojo T. J. Natl. Cancer Inst. 2000, 92: 182 - 19
Mitra A.Sept D. Biochemistry 2004, 43: 13955 - 20
Löwe J.Li H.Downing KH.Nogales E. J. Mol. Biol. 2001, 313: 1045 - 21
Ravelli RB.Gigant B.Curmi PA.Jourdain I.Lachkar S.Sobel A.Knossow M. Nature 2004, 428: 198 - 22
Guex N.Peitsch MC. Electrophoresis 1997, 18: 2714 ; online at http://www.expasy.org/spdbv/ - 23
Panda D.Ananthnarayan V.Larson G.Shih C.Jordan MA.Wilson L. Biochemistry 2000, 39: 14121 - 24
Panda D.Himes RH.Moore RE.Wilson L.Jordan MA. Biochemistry 1997, 36: 12948 - 25
Chen BD.-M.Nakeff A.Valeriote F. Int. J. Cancer 1998, 77: 869 - 26
Kerksiek K.Mejillano MR.Schwartz RE.Georg GI.Himes RH. FEBS Lett. 1995, 377: 59 - 27
Smith CD.Zhang X. J. Biol. Chem. 1996, 271: 6192 - 28
Mooberry SL.Taoka CR.Busquets L. Cancer Lett. 1996, 107: 53 - 29
Bai R.Durso NA.Sackett DL.Hamel E. Biochemistry 1999, 38: 14302 - 30
Bai R.Pettit GR.Hamel E. J. Biol. Chem. 1990, 265: 17141 - 31
Barbier P.Gregoire C.Devred F.Sarrazin M.Peyrot V. Biochemistry 2001, 40: 13510 - 32
Panda D.Deluca K.Williams D.Jordan MA.Wilson L. Proc. Natl. Acad. Sci. U.S.A. 1998, 95: 9313 - 33
Watts NR.Cheng N.West W.Steven AC.Sackett DL. Biochemistry 2002, 41: 12662 - 34
Boukari H.Nossal R.Sackett DL. Biochemistry 2003, 42: 1292 - 35
Smith CD.Zhang X.Mooberry SL.Patterson GM.Moore RE. Cancer Res. 1994, 54: 3779 - 36
Foster BJ.Fortuna M.Media J.Wiegand RA.Valeriote FA. Invest. New Drugs 1999, 16: 199 - 37
Mooberry SL.Busquets L.Tien G. Int. J. Cancer 1997, 73: 440 - 38
Drew L.Fine RL.Do TN.Douglas GP.Petrylak DP. Clin. Cancer Res. 2002, 8: 3922 - 39
Lu K.Dempsey J.Schultz RM.Shih C.Teicher BA. Cancer Chemother. Pharmacol. 2001, 47: 170 - 40
Shih C.Teicher BA. Curr. Pharm. Des. 2001, 7: 1259 - 41
Menon K.Alvarez E.Forler P.Phares V.Amsrud T.Shih C.Al-Awar RS.Teicher BA. Cancer Chemother. Pharmacol. 2000, 46: 142 - 42
Liang J.Moore RE.Moher ED.Munroe JE.Al-awar RS.Hay DA.Varie DL.Zhang TY.Aikins JA.Martinelli MJ.Shih C.Ray JE.Gibson LL.Vasudevan V.Polin L.White K.Kushner J.Simpson C.Pugh S.Corbett TH. Invest. New Drugs 2005, 23: 213 - 43
Sessa C.Weigang-Köhler K.Pagani O.Greim G.Mor O.Pas TD.Burgess M.Weimer I.Johnson R. Eur. J. Cancer 2002, 38: 2388 - 44
D’Agostino G.Campo JD.Mellado B.Izquierdo MA.Minarik T.Cirri L.Marini L.Perez-Gracia JL.Scambia G. Int. J. Gynecol. Cancer 2006, 16: 71 - 45
Moore RE.Corbett TH.Patterson GML.Valeriote FA. Curr. Pharm. Des. 1996, 2: 317 - 46
Boinpally RR.Polin L.Zhou S.-L.Jasti BR.Wiegand RA.White K.Kushner J.Horwitz JP.Corbett TH.Parchment RE. Cancer Chemother. Pharmacol. 2003, 52: 25 - 47
de Muys J.-M.Rej R.Nguyen D.Go B.Fortin S.Lavallée J.-F. Bioorg. Med. Chem. Lett. 1996, 6: 1111 - 48
Georg GI.Ali SM.Stella VJ.Waugh WN.Himes RH. Bioorg. Med. Chem. Lett. 1998, 8: 1959 - 49
Kobayashi M.Wang W.Ohyabu N.Kurosu M.Kitagawa I. Chem. Pharm. Bull. 1995, 43: 1598 - 50
Patel VF.Andis SL.Kennedy JH.Ray JE.Schultz RM. J. Med. Chem. 1999, 42: 2588 - 51
Al-awar RS.Corbett TH.Ray JE.Polin L.Kennedy JH.Wagner MM.Williams DC. Mol. Cancer. Ther. 2004, 3: 1061 - 52
Buck SB.Huff JK.Himes RH.Georg GI. J. Med. Chem. 2004, 47: 696 - 53
Shih C.Gossett LS.Gruber JM.Grossman CS.Andis SL.Schultz RM.Worzalla JF.Corbett TH.Metz JT. Bioorg. Med. Chem. Lett. 1999, 9: 69 - 54
Varie DL.Shih C.Hay DA.Andis SL.Corbett TH.Gossett LS.Janisse SK.Martinelli MJ.Moher ED.Schultz RM.Toth JE. Bioorg. Med. Chem. Lett. 1999, 9: 369 - 55
Buck SB.Huff JK.Himes RH.Georg GI. J. Med. Chem. 2004, 47: 3697 - 56
Murakami N.Tamura S.Wang W.Takagi T.Kobayashi M. Tetrahedron 2001, 57: 4323 - 57
Norman BH.Hemscheidt T.Schultz RM.Andis SL. J. Org. Chem. 1998, 63: 5288 - 58
Murakami N.Wang W.Tamura S.Kobayashi M. Bioorg. Med. Chem. Lett. 2000, 10: 1823 - 59
Murakami N.Wang W.Ohyabu N.Ito T.Tamura S.Aoki S.Kobayashi M.Kitagawa I. Tetrahedron 2000, 56: 9121 - 60
Furuyama M.Shimizu I. Tetrahedron: Asymmetry 1998, 9: 1351 - 61
Ali SM.Georg GI. Tetrahedron Lett. 1997, 38: 1703 - 62
Dhokte UP.Khau VV.Hutchinson DR.Martinelli MJ. Tetrahedron Lett. 1998, 39: 8771 - 63
Eggen M.Mossman CJ.Buck SB.Nair SK.Bhat L.Ali SM.Reiff A.Boge TC.Georg GI. J. Org. Chem. 2000, 65: 7792 - 64
White JD.Hong J.Robarge LA. J. Org.Chem. 1999, 64: 6206 - 65
Phukan P.Sasmal S.Maier ME. Eur. J. Org. Chem. 2003, 1733 - 66
Martin SF.Dodge JA. Tetrahedron Lett. 1991, 32: 3017 - 67
Danner P.Bauer M.Phukan P.Maier ME. Eur. J. Org. Chem. 2005, 317 - 68
Ghosh AK.Bishoff A. Org. Lett. 2000, 2: 1573 - 69
Ghosh AK.Bishoff A. Eur. J. Org. Chem. 2004, 1231 - 70
Rej R.Nguyen D.Go B.Fortin S.Lavallée J.-F. J. Org. Chem. 1996, 61: 6289 - 71
Salamonczyk GM.Han K.Guo Z.Sih CJ. J. Org. Chem. 1996, 61: 6893 - 72
Varie DL.Brennan J.Briggs B.Cronin JS.Hay DA.Rieck JA.Zmijewski MJ. Tetrahedron Lett. 1998, 39: 8405 - 73
Liang J.Hoard DW.Khau VV.Martinelli MJ.Moher ED.Moore RE.Tius MA. J. Org. Chem. 1999, 64: 1459 - 74
Christopher JA.Kocienski PJ.Kuhl A.Bell R. Synlett 2000, 463 - 75
Cooksey JC.Gunn A.Kocienski PJ.Kuhl A.Uppal S.Christopher JA.Bell R. Org. Biomol. Chem. 2004, 2: 1719 - 76
Martin SF.Dodge JA. Chem. Lett. 1984, 1389 - 77
Ghosh AK.Swanson L. J. Org. Chem. 2003, 68: 9823 - 78
Hoard DW.Moher ED.Martinelli MJ.Norman BH. Org. Lett. 2002, 4: 1813 - 79
Gardinier KM.Leahy JW. J. Org. Chem. 1997, 62: 7098 - 80
Liang J.Moher ED.Moore RE.Hoard DW. J. Org. Chem. 2000, 65: 3143 - 81
Pousset C.Haddad M.Larchevêque M. Tetrahedron 2001, 57: 7163 - 82
Li L.-H.Tius MA. Org. Lett. 2002, 4: 1637 - 83
Tripathy NK.Georg GI. Tetrahedron Lett. 2004, 45: 5309 - 84
Mast CA.Eißler S.Stoncius A.Stammler H.-G.Neumann B.Sewald N. Chem. Eur. J. 2005, 11: 4667 - 85
Stoncius A.Mast CA.Sewald N. Tetrahedron: Asymmetry 2000, 11: 3849 - 86
O’Donnell MJ.Bennett WD.Wu S. J. Am. Chem. Soc. 1989, 111: 2353 - 87
Aikins JA,Briggs BS,Zhang TY, andZmijewski MJ. inventors; US Patent 6376230 B1. ; Chem. Abstr. 2002, 136, 341000 - 88
Fray AH. Tetrahedron: Asymmetry 1998, 9: 2777 - 89
Barrow RA.Moore RE.Li L.-H.Tius MA. Tetrahedron 2000, 56: 3339 - 90
Vidya R.Eggen MJ.Georg GI.Himes RH. Bioorg. Med. Chem. Lett. 2003, 13: 757 - 91
White JD.Hong J.Robarge LA. Tetrahedron Lett. 1998, 39: 8779 - 92
Kobayashi M.Kurosu M.Wang W.Kitagawa I. Chem. Pharm. Bull. 1994, 42: 2394 - 93
Vidya R.Eggen MJ.Nair SK.Georg GI.Himes RH. J. Org. Chem. 2003, 68: 9687 - 94
Eggen MJ.Nair SK.Georg GI. Org. Lett. 2001, 3: 1813 - 95
Beck ZQ.Aldrich CC.Magarvey NA.Georg GI.Sherman DH. Biochemistry 2005, 44: 13457 - 96
Al-awar RS.Ray JE.Schultz RM.Andis SL.Kennedy JH.Moore RE.Liang J.Golakoti T.Subbaraju GV.Corbett TH. J. Med. Chem. 2003, 46: 2985 - 97
Martinelli MJ.Vaidyanathan R.Khau VV.Staszak MA. Tetrahedron Lett. 2002, 43: 3365